Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
BNT164b1 / BioNTech
NCT05547464: Safety and Immune Responses After Vaccination with Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers	Active, not recruiting	1/2	732	RoW	BNT164a1, BNT164b1, Placebo	BioNTech SE	Tuberculosis	06/26	05/27
NCT05537038: Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers	Active, not recruiting	1	120	Europe	BNT164a1, BNT164b1, Placebo	BioNTech SE	Tuberculosis	06/25	01/26